本報告已在2011年10月11日停止出版。
更改為出版
Biotechnology: Global Industry Guide
出版日期 : 2011年09月
商品編碼: 217372
Abstract
Datamonitor' s Biotechnology: Global Industry Guide is an essential resource
for top-level data and analysis covering the Biotechnology industry. It
includes detailed data on market size and segmentation, textual analysis of
the key trends and competitive landscape, and profiles of the leading
companies. This incisive report provides expert analysis on a global, regional
and country basis.
Scope of the Report
* Contains an executive summary and data on
value, volume and segmentation
* Provides textual analysis of the
industry' s prospects, competitive landscape and profiles of the leading
companies
* Incorporates in-depth five forces competitive environment analysis and
scorecards
* Covers the Global, European and Asia-Pacific markets as
well as individual chapters on 5 major markets (France, Germany, Japan, the UK
and the US).
* Includes a five-year forecast of the industry
Highlights
The global biotechnology market grew by 4% in 2009 to reach a value of $200.9
billion.
In 2014, the global biotechnology market is forecast to have a value of $318.4
billion, an increase of 58.5% since 2009.
Medical/Healthcare is the largest segment of the global biotechnology market,
accounting for 66.2% of the market' s total value.
Americas accounts for 48.4% of the global biotechnology market value.
Rapid market growth should encourage new players into the fray, but rivalry is
assessed as moderate in a market where the typical player is an SME.
Why you should buy this report
* Spot future trends and
developments
* Inform your business decisions
* Add weight
to presentations and marketing materials
* Save time carrying out
entry-level research
Market Definition
The biotechnology market consists of the development, manufacturing and
marketing of products based on advanced biotechnology research. The market
value reflects revenues of companies within this market from product sales,
licensing fees, royalties and research funding. Any currency conversions used
in the creation of this report have been calculated using constant 2009 annual
average exchange rates
Table of Contents
TABLE OF CONTENTS
EXECUTIVE SUMMARY 2
INTRODUCTION 19
What is this
report about? 19
Who is the target reader? 19
Market definition 19
GLOBAL BIOTECHNOLOGY 20
MARKET OVERVIEW 20
MARKET VALUE 21
MARKET
SEGMENTATION I 22
MARKET SEGMENTATION II 23
FIVE FORCES ANALYSIS
24
MARKET FORECASTS 31
BIOTECHNOLOGY IN ASIAPACIFIC 33
MARKET
OVERVIEW 33
MARKET VALUE 34
MARKET SEGMENTATION I 35
MARKET
SEGMENTATION II 36
FIVE FORCES ANALYSIS 37
MARKET FORECASTS 45
BIOTECHNOLOGY IN EUROPE 47
MARKET OVERVIEW 47
MARKET VALUE 48
MARKET SEGMENTATION I 49
MARKET SEGMENTATION II 50
FIVE FORCES
ANALYSIS 51
MARKET FORECASTS 59
BIOTECHNOLOGY IN BELGIUM 61
MARKET
OVERVIEW 61
MARKET VALUE 62
MARKET SEGMENTATION I 63
MARKET
SEGMENTATION II 64
FIVE FORCES ANALYSIS 65
MARKET FORECASTS 72
MACROECONOMIC INDICATORS 73
BIOTECHNOLOGY IN CANADA 76
MARKET OVERVIEW
76
MARKET VALUE 77
MARKET SEGMENTATION I 78
MARKET SEGMENTATION II
79
FIVE FORCES ANALYSIS 80
MARKET FORECASTS 86
MACROECONOMIC
INDICATORS 87
BIOTECHNOLOGY IN CHINA 90
MARKET OVERVIEW 90
MARKET
VALUE 91
MARKET SEGMENTATION I 92
MARKET SEGMENTATION II 93
FIVE
FORCES ANALYSIS 94
MARKET FORECASTS 101
MACROECONOMIC INDICATORS
102
BIOTECHNOLOGY IN FRANCE 105
MARKET OVERVIEW 105
MARKET VALUE
106
MARKET SEGMENTATION I 107
MARKET SEGMENTATION II 108
FIVE
FORCES ANALYSIS 109
MARKET FORECASTS 116
MACROECONOMIC INDICATORS
117
BIOTECHNOLOGY IN GERMANY 120
MARKET OVERVIEW 120
MARKET VALUE
121
MARKET SEGMENTATION I 122
MARKET SEGMENTATION II 123
FIVE
FORCES ANALYSIS 124
MARKET FORECASTS 131
MACROECONOMIC INDICATORS
132
BIOTECHNOLOGY IN ITALY 135
MARKET OVERVIEW 135
MARKET VALUE
136
MARKET SEGMENTATION I 137
MARKET SEGMENTATION II 138
FIVE
FORCES ANALYSIS 139
MARKET FORECASTS 146
MACROECONOMIC INDICATORS
147
BIOTECHNOLOGY IN JAPAN 150
MARKET OVERVIEW 150
MARKET VALUE
151
MARKET SEGMENTATION I 152
MARKET SEGMENTATION II 153
FIVE
FORCES ANALYSIS 154
MARKET FORECASTS 161
MACROECONOMIC INDICATORS
162
BIOTECHNOLOGY IN THE NETHERLANDS 164
MARKET OVERVIEW 164
MARKET VALUE 165
MARKET SEGMENTATION I 166
MARKET SEGMENTATION II
167
FIVE FORCES ANALYSIS 168
MARKET FORECASTS 175
MACROECONOMIC
INDICATORS 176
BIOTECHNOLOGY IN SPAIN 178
MARKET OVERVIEW 178
MARKET VALUE 179
MARKET SEGMENTATION I 180
MARKET SEGMENTATION II
181
FIVE FORCES ANALYSIS 182
MARKET FORECASTS 189
MACROECONOMIC
INDICATORS 190
BIOTECHNOLOGY IN THE UNITED KINGDOM 193
MARKET OVERVIEW
193
MARKET VALUE 194
MARKET SEGMENTATION I 195
MARKET SEGMENTATION
II 196
FIVE FORCES ANALYSIS 197
MARKET FORECASTS 204
MACROECONOMIC
INDICATORS 205
BIOTECHNOLOGY IN THE UNITED STATES 208
MARKET OVERVIEW
208
MARKET VALUE 209
MARKET SEGMENTATION I 210
MARKET SEGMENTATION
II 211
FIVE FORCES ANALYSIS 212
MARKET FORECASTS 219
MACROECONOMIC
INDICATORS 220
COMPANY PROFILES 223
LEADING COMPANIES 223
APPENDIX
243
Data Research Methodology 243
About Datamonitor 244
Disclaimer
244
LIST OF TABLES
Table 1: Global biotechnology market value: $
billion, 2005-09 21
Table 2: Global biotechnology market
segmentation I:% share, by value, 2009 22
Table 3: Global biotechnology
market segmentation II: % share, by value, 2009 23
Table 4: Global
biotechnology market value forecast: $ billion, 2009-14 31
Table 5:
Asia-Pacific biotechnology market value: $ billion, 2005-09 34
Table
6: Asia-Pacific biotechnology market segmentation I:% share, by value, 2009
35
Table 7: Asia-Pacific biotechnology market segmentation II: % share, by
value, 2009 36
Table 8: Asia-Pacific biotechnology market value forecast:
$ billion, 2009-14 45
Table 9: Europe biotechnology market value: $
billion, 2005-09 48
Table 10: Europe biotechnology market
segmentation I:% share, by value, 2009 49
Table 11: Europe biotechnology
market segmentation II: % share, by value, 2009 50
Table 12: Europe
biotechnology market value forecast: $ billion, 2009-14 59
Table 13:
Belgium biotechnology market value: $ billion, 2005-09 62
Table 14:
Belgium biotechnology market segmentation I:% share, by value, 2009 63
Table 15: Belgium biotechnology market segmentation II: % share, by value,
2009 64
Table 16: Belgium biotechnology market value forecast: $ billion,
2009-14 72
Table 17: Belgium size of population (million),
2005-09 73
Table 18: Belgium gdp (constant 2000 prices, $ billion),
2005-09 73
Table 19: Belgium gdp (current prices, $ billion),
2005-09 74
Table 20: Belgium inflation, 2005-09 74
Table
21: Belgium consumer price index (absolute), 2005-09 75
Table 22:
Belgium exchange rate, 2005-09 75
Table 23: Canada biotechnology
market value: $ billion, 2005-09 77
Table 24: Canada biotechnology
market segmentation I:% share, by value, 2009 78
Table 25: Canada
biotechnology market segmentation II: % share, by value, 2009 79
Table 26:
Canada biotechnology market value forecast: $ billion, 2009-14 86
Table 27: Canada size of population (million), 2005-09 87
Table 28:
Canada gdp (constant 2000 prices, $ billion), 2005-09 87
Table 29:
Canada gdp (current prices, $ billion), 2005-09 88
Table 30: Canada
inflation, 2005-09 88
Table 31: Canada consumer price index
(absolute), 2005-09 89
Table 32: Canada exchange rate, 2005-09
89
Table 33: China biotechnology market value: $ billion, 2005-09
91
Table 34: China biotechnology market segmentation I:% share, by value,
2009 92
Table 35: China biotechnology market segmentation II: % share, by
value, 2009 93
Table 36: China biotechnology market value forecast: $
billion, 2009-14 101
Table 37: China size of population (million),
2005-09 102
Table 38: China gdp (constant 2000 prices, $ billion),
2005-09 102
Table 39: China gdp (current prices, $ billion),
2005-09 103
Table 40: China inflation, 2005-09 103
Table
41: China consumer price index (absolute), 2005-09 104
Table 42:
China exchange rate, 2005-09 104
Table 43: France biotechnology
market value: $ billion, 2005-09 106
Table 44: France biotechnology
market segmentation I:% share, by value, 2009 107
Table 45: France
biotechnology market segmentation II: % share, by value, 2009 108
Table
46: France biotechnology market value forecast: $ billion, 2009-14
116
Table 47: France size of population (million), 2005-09 117
Table 48: France gdp (constant 2000 prices, $ billion), 2005-09 117
Table 49: France gdp (current prices, $ billion), 2005-09 118
Table
50: France inflation, 2005-09 118
Table 51: France consumer price
index (absolute), 2005-09 119
Table 52: France exchange rate,
2005-09 119
Table 53: Germany biotechnology market value: $ billion,
2005-09 121
Table 54: Germany biotechnology market segmentation I:%
share, by value, 2009 122
Table 55: Germany biotechnology market
segmentation II: % share, by value, 2009 123
Table 56: Germany
biotechnology market value forecast: $ billion, 2009-14 131
Table
57: Germany size of population (million), 2005-09 132
Table 58:
Germany gdp (constant 2000 prices, $ billion), 2005-09 132
Table 59:
Germany gdp (current prices, $ billion), 2005-09 133
Table 60:
Germany inflation, 2005-09 133
Table 61: Germany consumer price
index (absolute), 2005-09 134
Table 62: Germany exchange rate,
2005-09 134
Table 63: Italy biotechnology market value: $ billion,
2005-09 136
Table 64: Italy biotechnology market segmentation I:%
share, by value, 2009 137
Table 65: Italy biotechnology market
segmentation II: % share, by value, 2009 138
Table 66: Italy biotechnology
market value forecast: $ billion, 2009-14 146
Table 67: Italy size
of population (million), 2005-09 147
Table 68: Italy gdp (constant
2000 prices, $ billion), 2005-09 147
Table 69: Italy gdp (current
prices, $ billion), 2005-09 148
Table 70: Italy inflation,
2005-09 148
Table 71: Italy consumer price index (absolute),
2005-09 149
Table 72: Italy exchange rate, 2005-09 149
Table 73: Japan biotechnology market value: $ billion, 2005-09 151
Table 74: Japan biotechnology market segmentation I:% share, by value, 2009
152
Table 75: Japan biotechnology market segmentation II: % share, by
value, 2009 153
Table 76: Japan biotechnology market value forecast: $
billion, 2009-14 161
Table 77: Japan size of population (million),
2005-09 162
Table 78: Japan gdp (constant 2000 prices, $ billion),
2005-09 162
Table 79: Japan gdp (current prices, $ billion),
2005-09 162
Table 80: Japan inflation, 2005-09 163
Table
81: Japan consumer price index (absolute), 2005-09 163
Table 82:
Japan exchange rate, 2005-09 163
Table 83: Netherlands biotechnology
market value: $ million, 2005-09 165
Table 84: Netherlands
biotechnology market segmentation I:% share, by value, 2009 166
Table 85:
Netherlands biotechnology market segmentation II: % share, by value, 2009
167
Table 86: Netherlands biotechnology market value forecast: $ million,
2009-14 175
Table 87: Netherlands size of population (million),
2005-09 176
Table 88: Netherlands gdp (constant 2000 prices, $
billion), 2005-09 176
Table 89: Netherlands gdp (current prices, $
billion), 2005-09 176
Table 90: Netherlands inflation, 2005-09
177
Table 91: Netherlands consumer price index (absolute), 2005-09
177
Table 92: Netherlands exchange rate, 2005-09 177
Table 93:
Spain biotechnology market value: $ billion, 2005-09 179
Table 94:
Spain biotechnology market segmentation I:% share, by value, 2009 180
Table 95: Spain biotechnology market segmentation II: % share, by value, 2009
181
Table 96: Spain biotechnology market value forecast: $ billion,
2009-14 189
Table 97: Spain size of population (million),
2005-09 190
Table 98: Spain gdp (constant 2000 prices, $ billion),
2005-09 190
Table 99: Spain gdp (current prices, $ billion),
2005-09 191
Table 100: Spain inflation, 2005-09 191
Table
101: Spain consumer price index (absolute), 2005-09 192
Table 102:
Spain exchange rate, 2005-09 192
Table 103: United Kingdom
biotechnology market value: $ billion, 2005-09 194
Table 104: United
Kingdom biotechnology market segmentation I:% share, by value, 2009 195
Table 105: United Kingdom biotechnology market segmentation II: % share, by
value, 2009 196
Table 106: United Kingdom biotechnology market value
forecast: $ billion, 2009-14 204
Table 107: United Kingdom size of
population (million), 2005-09 205
Table 108: United Kingdom gdp
(constant 2000 prices, $ billion), 2005-09 205
Table 109: United
Kingdom gdp (current prices, $ billion), 2005-09 206
Table 110:
United Kingdom inflation, 2005-09 206
Table 111: United Kingdom
consumer price index (absolute), 2005-09 207
Table 112: United
Kingdom exchange rate, 2005-09 207
Table 113: United States
biotechnology market value: $ billion, 2005-09 209
Table 114: United
States biotechnology market segmentation I:% share, by value, 2009 210
Table 115: United States biotechnology market segmentation II: % share, by
value, 2009 211
Table 116: United States biotechnology market value
forecast: $ billion, 2009-14 219
Table 117: United States size of
population (million), 2005-09 220
Table 118: United States gdp
(constant 2000 prices, $ billion), 2005-09 220
Table 119: United
States gdp (current prices, $ billion), 2005-09 221
Table 120:
United States inflation, 2005-09 221
Table 121: United States
consumer price index (absolute), 2005-09 222
Table 122: United
States exchange rate, 2005-09 222
Table 123: Merck KGaA: key facts
223
Table 124: Merck KGaA: key financials ($) 226
Table 125: Merck
KGaA: key financials (€) 226
Table 126: Merck KGaA: key financial
ratios 227
Table 127: Novartis AG: key facts 229
Table 128: Novartis
AG: key financials ($) 231
Table 129: Novartis AG: key financial ratios
231
Table 130: Pfizer Inc.: key facts 234
Table 131: Pfizer Inc.: key
financials ($) 235
Table 132: Pfizer Inc.: key financial ratios 236
Table 133: AstraZeneca PLC: key facts 238
Table 134: AstraZeneca PLC: key
financials ($) 240
Table 135: AstraZeneca PLC: key financial ratios
241
LIST OF FIGURES
Figure 1: Global biotechnology market
value: $ billion, 2005-09 21
Figure 2: Global biotechnology market
segmentation I:% share, by value, 2009 22
Figure 3: Global biotechnology
market segmentation II: % share, by value, 2009 23
Figure 4: Forces
driving competition in the global biotechnology market, 2009 24
Figure 5:
Drivers of buyer power in the global biotechnology market, 2009 25
Figure
6: Drivers of supplier power in the global biotechnology market, 2009 26
Figure 7: Factors influencing the likelihood of new entrants in the global
biotechnology market, 2009 27
Figure 8: Factors influencing the threat of
substitutes in the global biotechnology market, 2009 29
Figure 9: Drivers
of degree of rivalry in the global biotechnology market, 2009 30
Figure
10: Global biotechnology market value forecast: $ billion, 2009-14
32
Figure 11: Asia-Pacific biotechnology market value: $ billion,
2005-09 34
Figure 12: Asia-Pacific biotechnology market segmentation
I:% share, by value, 2009 35
Figure 13: Asia-Pacific biotechnology market
segmentation II: % share, by value, 2009 36
Figure 14: Forces driving
competition in the biotechnology market in Asia-Pacific, 2009 37
Figure
15: Drivers of buyer power in the biotechnology market in Asia-Pacific, 2009
38
Figure 16: Drivers of supplier power in the biotechnology market in
Asia-Pacific, 2009 40
Figure 17: Factors influencing the likelihood of new
entrants in the biotechnology market in Asia-Pacific, 2009 41
Figure 18:
Factors influencing the threat of substitutes in the biotechnology market in
Asia-Pacific, 2009 43
Figure 19: Drivers of degree of rivalry in the
biotechnology market in Asia-Pacific, 2009 44
Figure 20: Asia-Pacific
biotechnology market value forecast: $ billion, 2009-14 46
Figure
21: Europe biotechnology market value: $ billion, 2005-09 48
Figure
22: Europe biotechnology market segmentation I:% share, by value, 2009 49
Figure 23: Europe biotechnology market segmentation II: % share, by value,
2009 50
Figure 24: Forces driving competition in the biotechnology market
in Europe, 2009 51
Figure 25: Drivers of buyer power in the biotechnology
market in Europe, 2009 52
Figure 26: Drivers of supplier power in the
biotechnology market in Europe, 2009 54
Figure 27: Factors influencing the
likelihood of new entrants in the biotechnology market in Europe, 2009 55
Figure 28: Factors influencing the threat of substitutes in the biotechnology
market in Europe, 2009 57
Figure 29: Drivers of degree of rivalry in the
biotechnology market in Europe, 2009 58
Figure 30: Europe biotechnology
market value forecast: $ billion, 2009-14 60
Figure 31: Belgium
biotechnology market value: $ billion, 2005-09 62
Figure 32: Belgium
biotechnology market segmentation I:% share, by value, 2009 63
Figure 33:
Belgium biotechnology market segmentation II: % share, by value, 2009 64
Figure 34: Forces driving competition in the biotechnology market in Belgium,
2009 65
Figure 35: Drivers of buyer power in the biotechnology market in
Belgium, 2009 66
Figure 36: Drivers of supplier power in the biotechnology
market in Belgium, 2009 67
Figure 37: Factors influencing the likelihood
of new entrants in the biotechnology market in Belgium, 2009 68
Figure 38:
Factors influencing the threat of substitutes in the biotechnology market in
Belgium, 2009 70
Figure 39: Drivers of degree of rivalry in the
biotechnology market in Belgium, 2009 71
Figure 40: Belgium biotechnology
market value forecast: $ billion, 2009-14 72
Figure 41: Canada
biotechnology market value: $ billion, 2005-09 77
Figure 42: Canada
biotechnology market segmentation I:% share, by value, 2009 78
Figure 43:
Canada biotechnology market segmentation II: % share, by value, 2009 79
Figure 44: Forces driving competition in the biotechnology market in Canada,
2009 80
Figure 45: Drivers of buyer power in the biotechnology market in
Canada, 2009 81
Figure 46: Drivers of supplier power in the biotechnology
market in Canada, 2009 82
Figure 47: Factors influencing the likelihood of
new entrants in the biotechnology market in Canada, 2009 83
Figure 48:
Factors influencing the threat of substitutes in the biotechnology market in
Canada, 2009 84
Figure 49: Drivers of degree of rivalry in the
biotechnology market in Canada, 2009 85
Figure 50: Canada biotechnology
market value forecast: $ billion, 2009-14 86
Figure 51: China
biotechnology market value: $ billion, 2005-09 91
Figure 52: China
biotechnology market segmentation I:% share, by value, 2009 92
Figure 53:
China biotechnology market segmentation II: % share, by value, 2009 93
Figure 54: Forces driving competition in the biotechnology market in China,
2009 94
Figure 55: Drivers of buyer power in the biotechnology market in
China, 2009 95
Figure 56: Drivers of supplier power in the biotechnology
market in China, 2009 96
Figure 57: Factors influencing the likelihood of
new entrants in the biotechnology market in China, 2009 97
Figure 58:
Factors influencing the threat of substitutes in the biotechnology market in
China, 2009 99
Figure 59: Drivers of degree of rivalry in the
biotechnology market in China, 2009 100
Figure 60: China biotechnology
market value forecast: $ billion, 2009-14 101
Figure 61: France
biotechnology market value: $ billion, 2005-09 106
Figure 62: France
biotechnology market segmentation I:% share, by value, 2009 107
Figure 63:
France biotechnology market segmentation II: % share, by value, 2009 108
Figure 64: Forces driving competition in the biotechnology market in France,
2009 109
Figure 65: Drivers of buyer power in the biotechnology market in
France, 2009 110
Figure 66: Drivers of supplier power in the biotechnology
market in France, 2009 111
Figure 67: Factors influencing the likelihood
of new entrants in the biotechnology market in France, 2009 112
Figure 68:
Factors influencing the threat of substitutes in the biotechnology market in
France, 2009 114
Figure 69: Drivers of degree of rivalry in the
biotechnology market in France, 2009 115
Figure 70: France biotechnology
market value forecast: $ billion, 2009-14 116
Figure 71: Germany
biotechnology market value: $ billion, 2005-09 121
Figure 72:
Germany biotechnology market segmentation I:% share, by value, 2009 122
Figure 73: Germany biotechnology market segmentation II: % share, by value,
2009 123
Figure 74: Forces driving competition in the biotechnology market
in Germany, 2009 124
Figure 75: Drivers of buyer power in the
biotechnology market in Germany, 2009 125
Figure 76: Drivers of supplier
power in the biotechnology market in Germany, 2009 126
Figure 77: Factors
influencing the likelihood of new entrants in the biotechnology market in
Germany, 2009 127
Figure 78: Factors influencing the threat of substitutes
in the biotechnology market in Germany, 2009 129
Figure 79: Drivers of
degree of rivalry in the biotechnology market in Germany, 2009 130
Figure
80: Germany biotechnology market value forecast: $ billion, 2009-14
131
Figure 81: Italy biotechnology market value: $ billion, 2005-09
136
Figure 82: Italy biotechnology market segmentation I:% share, by
value, 2009 137
Figure 83: Italy biotechnology market segmentation II: %
share, by value, 2009 138
Figure 84: Forces driving competition in the
biotechnology market in Italy, 2009 139
Figure 85: Drivers of buyer power
in the biotechnology market in Italy, 2009 140
Figure 86: Drivers of
supplier power in the biotechnology market in Italy, 2009 141
Figure 87:
Factors influencing the likelihood of new entrants in the biotechnology market
in Italy, 2009 142
Figure 88: Factors influencing the threat of
substitutes in the biotechnology market in Italy, 2009 144
Figure 89:
Drivers of degree of rivalry in the biotechnology market in Italy, 2009
145
Figure 90: Italy biotechnology market value forecast: $ billion,
2009-14 146
Figure 91: Japan biotechnology market value: $ billion,
2005-09 151
Figure 92: Japan biotechnology market segmentation I:%
share, by value, 2009 152
Figure 93: Japan biotechnology market
segmentation II: % share, by value, 2009 153
Figure 94: Forces driving
competition in the biotechnology market in Japan, 2009 154
Figure 95:
Drivers of buyer power in the biotechnology market in Japan, 2009 155
Figure 96: Drivers of supplier power in the biotechnology market in Japan,
2009 156
Figure 97: Factors influencing the likelihood of new entrants in
the biotechnology market in Japan, 2009 157
Figure 98: Factors influencing
the threat of substitutes in the biotechnology market in Japan, 2009 159
Figure 99: Drivers of degree of rivalry in the biotechnology market in Japan,
2009 160
Figure 100: Japan biotechnology market value forecast: $ billion,
2009-14 161
Figure 101: Netherlands biotechnology market value: $
million, 2005-09 165
Figure 102: Netherlands biotechnology market
segmentation I:% share, by value, 2009 166
Figure 103: Netherlands
biotechnology market segmentation II: % share, by value, 2009 167
Figure
104: Forces driving competition in the biotechnology market in the
Netherlands, 2009 168
Figure 105: Drivers of buyer power in the
biotechnology market in the Netherlands, 2009 169
Figure 106: Drivers of
supplier power in the biotechnology market in the Netherlands, 2009 170
Figure 107: Factors influencing the likelihood of new entrants in the
biotechnology market in the Netherlands, 2009 171
Figure 108: Factors
influencing the threat of substitutes in the biotechnology market in the
Netherlands, 2009 173
Figure 109: Drivers of degree of rivalry in the
biotechnology market in the Netherlands, 2009 174
Figure 110: Netherlands
biotechnology market value forecast: $ million, 2009-14 175
Figure
111: Spain biotechnology market value: $ billion, 2005-09 179
Figure
112: Spain biotechnology market segmentation I:% share, by value, 2009 180
Figure 113: Spain biotechnology market segmentation II: % share, by value,
2009 181
Figure 114: Forces driving competition in the biotechnology
market in Spain, 2009 182
Figure 115: Drivers of buyer power in the
biotechnology market in Spain, 2009 183
Figure 116: Drivers of supplier
power in the biotechnology market in Spain, 2009 184
Figure 117: Factors
influencing the likelihood of new entrants in the biotechnology market in
Spain, 2009 185
Figure 118: Factors influencing the threat of substitutes
in the biotechnology market in Spain, 2009 187
Figure 119: Drivers of
degree of rivalry in the biotechnology market in Spain, 2009 188
Figure
120: Spain biotechnology market value forecast: $ billion, 2009-14
189
Figure 121: United Kingdom biotechnology market value: $ billion,
2005-09 194
Figure 122: United Kingdom biotechnology market
segmentation I:% share, by value, 2009 195
Figure 123: United Kingdom
biotechnology market segmentation II: % share, by value, 2009 196
Figure
124: Forces driving competition in the biotechnology market in the United
Kingdom, 2009 197
Figure 125: Drivers of buyer power in the biotechnology
market in the United Kingdom, 2009 198
Figure 126: Drivers of supplier
power in the biotechnology market in the United Kingdom, 2009 200
Figure
127: Factors influencing the likelihood of new entrants in the biotechnology
market in the United Kingdom, 2009 201
Figure 128: Factors influencing the
threat of substitutes in the biotechnology market in the United Kingdom, 2009
202
Figure 129: Drivers of degree of rivalry in the biotechnology market
in the United Kingdom, 2009 203
Figure 130: United Kingdom biotechnology
market value forecast: $ billion, 2009-14 204
Figure 131: United
States biotechnology market value: $ billion, 2005-09 209
Figure
132: United States biotechnology market segmentation I:% share, by value, 2009
210
Figure 133: United States biotechnology market segmentation II: %
share, by value, 2009 211
Figure 134: Forces driving competition in the
biotechnology market in the United States, 2009 212
Figure 135: Drivers of
buyer power in the biotechnology market in the United States, 2009 213
Figure 136: Drivers of supplier power in the biotechnology market in the
United States, 2009 214
Figure 137: Factors influencing the likelihood of
new entrants in the biotechnology market in the United States, 2009 215
Figure 138: Factors influencing the threat of substitutes in the biotechnology
market in the United States, 2009 217
Figure 139: Drivers of degree of
rivalry in the biotechnology market in the United States, 2009 218
Figure
140: United States biotechnology market value forecast: $ billion,
2009-14 219
Figure 141: Merck KGaA: revenues & profitability 227
Figure 142: Merck KGaA: assets & liabilities 228
Figure 143: Novartis AG:
revenues & profitability 232
Figure 144: Novartis AG: assets & liabilities
233
Figure 145: Pfizer Inc.: revenues & profitability 236
Figure 146:
Pfizer Inc.: assets & liabilities 237
Figure 147: AstraZeneca PLC:
revenues & profitability 241
Figure 148: AstraZeneca PLC: assets &
liabilities 242
